National Academies Press: OpenBook

Review of EPA's 2022 Draft Formaldehyde Assessment (2023)

Chapter: Appendix B: Public Session Agendas

« Previous: Appendix A: Committee Member Biographical Sketches
Suggested Citation:"Appendix B: Public Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2023. Review of EPA's 2022 Draft Formaldehyde Assessment. Washington, DC: The National Academies Press. doi: 10.17226/27153.
×

Appendix B
Public Session Agendas

Committee to Review EPA’s 2022 Draft Formaldehyde Assessment
Meeting 1
Wednesday, October 12, 2022 (all times listed in EST)

9:00 AM–2:00 PM Closed Session
2:00–5:30 PM Open Session
2:00 PM Welcome and Introductions
Kate Z. Guyton, PhD, National Academies Responsible Staff Officer
Jonathan M. Samet, MD, Committee Chair
2:25 PM Presentation on National Academies report Review of U.S. EPA’s ORD Staff Handbook for Developing IRIS Assessments: 2020 Version
Lisa Bero, PhD, Professor of Medicine and Public Health, University of Colorado
2:45 PM Committee Q&A
3:00 PM Break
3:15 PM EPA Presentation and Committee Q&A
Andrew Kraft, PhD, U.S. Environmental Protection Agency (EPA)
Thomas Bateson, ScD, EPA
5:00 PM Opportunity for Public Comment
5:30 PM End of Open Session

Thursday, October 13, 2022

9:00 AM–3:00 PM Closed Session

Meeting 2
Thursday, December 22, 2022 (all times listed in EST)

2:00–3:00 PM Closed Session
3:00–4:00 PM Open Session
3:00 PM Welcome and Introductions
Kate Z. Guyton, PhD, National Academies Responsible Staff Officer
Jonathan M. Samet, MD, Committee Chair
Suggested Citation:"Appendix B: Public Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2023. Review of EPA's 2022 Draft Formaldehyde Assessment. Washington, DC: The National Academies Press. doi: 10.17226/27153.
×
3:15 PM Opportunity for Public Comment
(Each commenter must register in advance and will have up to three minutes to comment. Comments will be invited from one speaker per organization, with preference given to those individuals and organizations who have not previously addressed the committee.)
4:00 PM End of Open Session

Meeting 3
Monday, January 30, 2023 (all times listed in EST)

9:00 AM–2:00 PM Closed Session
2:00–4:20 PM Open Session
2:00 PM Welcome and Introductions
Kate Z. Guyton, PhD, National Academies Responsible Staff Officer
Jonathan M. Samet, MD, Committee Chair
2:20 PM EPA Presentation and Committee Q&A
Andrew Kraft, PhD, EPA
Thomas Bateson, ScD, EPA
3:20 PM Opportunity for Public Comment
(Each commenter must register in advance and will have up to three minutes to comment. Comments will be invited from one speaker per organization, with preference given to those individuals and organizations who have not previously addressed the committee.)
4:20 PM End of Open Session
4:20–6:00 PM Closed Session

Tuesday, January 31, 2023

9:00 AM–2:00 PM Closed Session

Speaker Biographies

Thomas Bateson is senior epidemiologist with the U.S. Environmental Protection Agency’s (EPA’s) Office of Research and Development in the Center for Public Health and Environmental Assessment in Washington, DC. He earned his Master of Public Health in epidemiology and biostatistics from the University of California, Berkeley, and his Doctor of Science in epidemiologic methods from the Harvard T. H. Chan School of Public Health. Before joining EPA in 2006, Dr. Bateson studied the causes of birth defects, children’s health and development, the health of military personnel, and the effect of air pollution on the elderly using the case-crossover study design. At EPA, he works together with statisticians and toxicologists from multiple disciplines to identify hazards and to quantify the associated risks. Dr. Bateson has contributed to the EPA Integrated

Suggested Citation:"Appendix B: Public Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2023. Review of EPA's 2022 Draft Formaldehyde Assessment. Washington, DC: The National Academies Press. doi: 10.17226/27153.
×

Risk Information System (IRIS) assessments of environmental agents, such as asbestos, formaldehyde, hexavalent chromium, manganese and PFAS (PFDA, PFHxS, PFNA). He has also contributed to the Office of Chemical Safety and Pollution Protection’s Toxic Substances Control Act (TSCA) risk evaluations of chrysotile asbestos and carbon tetrachloride, as well as the Office of Water’s evaluations of PFOS and PFOA.

Lisa Bero is professor in the School of Public Health and the School of Medicine (General Internal Medicine) at the University of Colorado CU Anschutz Medical Center. She is also chief scientist at the Center for Bioethics and Humanities at that medical center. In addition, she is affiliated professor at the Charles Perkins Centre and School of Pharmacy in the Faculty of Medicine and Health at the University of Sydney. Dr. Bero is adjunct professor in the Department of Clinical Pharmacy and Institute for Health Policy Studies at the University of California, San Francisco. She is recognized for her methodological studies on bias (including publication/reporting, design, and funding biases) in the fields of clinical medicine (pharmaceuticals), tobacco control, and environmental research, and the use and implications of the evidence for prescribing decisions/policy. She investigates hidden biases in the design, conduct, and publication of research. For more than 20 years, Dr. Bero has been actively involved in the Cochrane Collaboration, a global organization that summarizes the best evidence from research to help make informed choices about health care. She served as a member of the National Academies Board on Health Care Services; Committee to Review the IRIS Process; and Committee on Conflicts of Interest in Medical Research, Education, and Practice. Dr. Bero received a PhD in pharmacology from Duke University.

Andrew D. Kraft is associate director of the Chemical and Pollutant Assessment Division within the Office of Research and Development at the U.S. Environmental Protection Agency (EPA). In this capacity, he oversees the development of Integrated Risk Information System (IRIS) assessments, as well as other technical products supporting Agency decision-making. Since joining EPA in 2011, he has led, coordinated, or contributed to dozens of human health assessments of environmental chemicals and has worked to advance methods for assessment development through collaboration with other EPA programs and regions, other federal and state agencies, and international organizations. Most relevant to the current project, Dr. Kraft has been chemical manager of the IRIS formaldehyde (inhalation) assessment since 2012 and has been a primary author on the IRIS Handbook since its inception. Before joining EPA, he received a PhD from the University of Wisconsin–Madison and did postdoctoral training at the U.S. National Institute of Environmental Health Sciences. Dr. Kraft’s graduate and postdoctoral studies were in neurotoxicology, focusing on protective mechanisms against neurodegenerative diseases and environmental insults.

List of Public Commenters

Meeting 1

Richard Albertini
Paul Bredwell
Harvey Checkoway
Rory Conolly
Pamela Dalton
James Enstrom
David Fischer
Bernard Gadagbui
John Graham
Suggested Citation:"Appendix B: Public Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2023. Review of EPA's 2022 Draft Formaldehyde Assessment. Washington, DC: The National Academies Press. doi: 10.17226/27153.
×
Mark Gruenwald
Stewart Holm
Kun Lu
Heather Lynch
Gary Marsh
Kenneth Mundt
Jessica Ryman-Rasmussen
Thomas Starr
Chad Thompson

Meeting 2

Paolo Boffeta
Kevin Bromberg
Tony Cox
Bernard Gadagbui
Paul Girard
Gary Huddleston
Kun Lu
Sahar Osman-Sypher
James Sherman
Bill Thompson
Lesley Witter
Clint Woods

Meeting 3

Preston Beard
Tokesha Collins-Wright
Harvey Clewell
James Enstrom
Chris Farmer
Adrian Krygsman
Kun Lu
Heather Lynch
Peggy Murray
Andy O’Hare
Leslie Recio
James Sherman
Suggested Citation:"Appendix B: Public Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2023. Review of EPA's 2022 Draft Formaldehyde Assessment. Washington, DC: The National Academies Press. doi: 10.17226/27153.
×
Page 125
Suggested Citation:"Appendix B: Public Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2023. Review of EPA's 2022 Draft Formaldehyde Assessment. Washington, DC: The National Academies Press. doi: 10.17226/27153.
×
Page 126
Suggested Citation:"Appendix B: Public Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2023. Review of EPA's 2022 Draft Formaldehyde Assessment. Washington, DC: The National Academies Press. doi: 10.17226/27153.
×
Page 127
Suggested Citation:"Appendix B: Public Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2023. Review of EPA's 2022 Draft Formaldehyde Assessment. Washington, DC: The National Academies Press. doi: 10.17226/27153.
×
Page 128
Next: Appendix C: Case Study: Hanrahan et al. (1984), Human Sensory Irritation »
Review of EPA's 2022 Draft Formaldehyde Assessment Get This Book
×
 Review of EPA's 2022 Draft Formaldehyde Assessment
Buy Paperback | $30.00 Buy Ebook | $24.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Formaldehyde is widely present in the environment and is one of the highest production chemicals by volume, used in manufactured goods including wood products, permanent press fabrics, and household products. It is also formed by combustion sources and is present in smoke from cigarettes and other tobacco products, and in emissions from gas stoves and open fireplaces. In carrying out its mission to protect human health, the U.S. Environmental Protection Agency (EPA) identifies and characterizes the health hazards of chemicals found in the environment through its Integrated Risk Information System (IRIS) Program, which has reviewed the human health hazards resulting from formaldehyde exposure in several assessments.

This report is a continuation of guidance from the National Academies on draft IRIS assessments of formaldehyde and other aspects of the IRIS program. This report reviews the 2022 Draft Assessment with regard to its adequacy and transparency in evaluating the scientific literature, use of appropriate methods to synthesize the current state-of-the science, and presentations of conclusions that are supported by the scientific evidence. The report concludes that the 2022 Draft Assessment follows the advice of prior National Academies reports and that its findings on hazard and quantitative risk are supported by the evidence identified. However, revisions are needed to ensure that users can find and follow the methods used in each step of the assessment for each health outcome.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!